Composecure (NYSE:GPGI) Releases Earnings Results, Beats Estimates By $0.03 EPS

Key Points

• CompoSecure reported second-quarter 2026 adjusted EPS of $0.17, beating analysts’ consensus estimate of $0.14 by $0.03.
• Management reiterated 2026 net-sales guidance of approximately $1.95 billion to $2.1 billion and its target of reducing leverage to about 3x by year-end, though the low end of the forecast is below some analyst expectations.
• Insiders bought more than 105,000 shares worth roughly $1.25 million during the last quarter, while analyst sentiment remained cautious: the consensus rating is “Hold” with a $15 price target, and the company faces reported securities-fraud lawsuit allegations.

Composecure (NYSE:GPGI - Get Free Report) announced its earnings results on Thursday. The company reported $0.17 EPS for the quarter, topping the consensus estimate of $0.14 by $0.03, Briefing.com reports.

Composecure Stock Performance

Shares of NYSE:GPGI traded down $0.16 during trading on Thursday, hitting $15.06. 1,218,779 shares of the company's stock were exchanged, compared to its average volume of 1,320,759. The company has a market capitalization of $4.37 billion, a price-to-earnings ratio of -6.28 and a beta of 0.86. The company's 50-day moving average is $14.16. Composecure has a 1-year low of $11.22 and a 1-year high of $26.78.

Insider Buying and Selling at Composecure

In related news, insider Kurt Schoen purchased 4,000 shares of the stock in a transaction dated Wednesday, May 13th. The stock was bought at an average cost of $12.58 per share, with a total value of $50,320.00. Following the purchase, the insider directly owned 586,317 shares in the company, valued at $7,375,867.86. The trade was a 0.69% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link. Also, Director Kevin M. Moriarty bought 3,956 shares of the business's stock in a transaction on Tuesday, May 26th. The stock was purchased at an average price of $12.64 per share, for a total transaction of $50,003.84. Following the completion of the acquisition, the director owned 71,011 shares of the company's stock, valued at approximately $897,579.04. This trade represents a 5.90% increase in their position. The SEC filing for this purchase provides additional information. Insiders acquired 105,237 shares of company stock valued at $1,245,734 over the last quarter. 18.40% of the stock is owned by corporate insiders.

Composecure News Roundup

Here are the key news stories impacting Composecure this week:

• Positive Sentiment: GPGI reported second-quarter 2026 adjusted earnings of $0.17 per share, exceeding analysts’ $0.14 consensus estimate. The earnings beat suggests better-than-expected profitability for the quarter. GPGI Reports Second Quarter 2026 Results
• Positive Sentiment: Management reiterated full-year 2026 net-sales guidance of approximately $1.95 billion to $2.1 billion and maintained its goal of reducing leverage to about 3x by year-end. Deleveraging could improve financial flexibility and investor confidence if achieved. GPGI Reiterates Fiscal 2026 Guidance
• Neutral Sentiment: The company’s outlook remains broadly intact, but the guidance range reaches $1.95 billion at the low end versus a roughly $2.1 billion analyst revenue expectation. This leaves limited room for an upside surprise and may be contributing to a cautious market reaction. GPGI Second-Quarter Earnings Call Transcript
• Negative Sentiment: Several law firms publicized securities-fraud class-action proceedings involving GPGI and alleged violations of federal securities laws tied to purchases between November 2025 and May 2026. The announcements may weigh on sentiment and create potential legal and financial risks, although the allegations have not been proven. GPGI Securities Law Lawsuit Announcement

Analysts Set New Price Targets

GPGI has been the subject of several research analyst reports. Wall Street Zen downgraded Composecure from a "sell" rating to a "strong sell" rating in a research report on Sunday, July 26th. Zacks Research cut Composecure from a "strong-buy" rating to a "hold" rating in a report on Tuesday, July 14th. JPMorgan Chase & Co. lowered their target price on Composecure from $22.00 to $15.00 and set a "neutral" rating for the company in a research note on Friday, May 15th. Finally, Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Composecure in a report on Thursday, June 11th. One research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $15.00.

Composecure Company Profile

CompoSecure, Inc manufactures and designs metal, plastic, composite ID, and proprietary financial transaction cards in the United States and internationally. Its primary metal form factors include embedded, metal veneer lite, metal veneer, and full metal products. The company also offers Arculus Cold Storage Wallet, a three-factor authentication solution, which comprise the Arculus Key card Cold Storage hardware device and companion Arculus Wallet mobile App to keep the Private Key in the Arculus Key card highly secure and store cryptocurrency and digital assets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source